Form D · Pharmaceuticals
SirnaMed Therapeutics Inc.
Sewickley, PA · CIK 0002031257
Offering snapshot reported Jul 25, 2024 · SEC filing
- Reported sold
- $1.25M Offering amount: $1.5M
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Jul 10, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 25, 2024 | Initial | $1,250,000 | No comparison | 9 | SEC filing |
Offering details
- Securities
- Option to acquire, Security to be acquired, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-519719
Simple Agreement for Future Equity
Source: Form D, filed Jul 25, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jing Zhou Hou | Director, Executive, Promoter |
| Song Li | Director, Executive, Promoter |
| Stanley Marks | Director |
| Phong Tran | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
1707 Dawn Dr.
Sewickley, PA, 15143
Phone: 412-996-2530
Sewickley, PA, 15143
Phone: 412-996-2530